Somehow, some way, you'll get through this. And no matter the outcome, you'll be grateful for the gift of time.
While most oncologists see only a few patients with myeloproliferative disorder in their careers, we see hundreds every month. This translates into a remarkable depth of experience and expertise, which we draw upon to give you personalized treatment.
Myeloproliferative disorder can be challenging to diagnose and treat, often requiring years of follow-up care and treatment. At MD Anderson, a team of experts, which may include hematologists, pathologists, advanced practice nurses and physician's assistants, as well as a specially trained support staff, plans your treatment for myeloproliferative disease by drawing upon the very latest advancements and therapies. It all begins with precise diagnosis by our specialized pathologists, who use advanced technology and skill to pinpoint the exact disorder.
Innovation and Research
At MD Anderson's Leukemia Center, you benefit from the most active research program in the United States. We have helped pioneer many advancements in MPD treatment, and we offer a wide range of clinical trials (research studies) of innovative treatments. The Department of Leukemia has established a Clinical Research Center for Myeloproliferative Neoplasia. This new research center will develop a comprehensive approach to understanding the biology of MPN through translational research on patient tissue samples, and work to find new, effective therapies for MPN.
Understanding a disease is the first step toward finding the right care. Get the facts about myeloproliferative disorder, including the different types, how it starts and who’s at risk.
Did You Know?
Myeloproliferative disorder has a wide range of symptoms and no known cause.